Effects of Multimodal Analgesia on Serum MCP-1, BDNF, and MiRNA-124 in Hysterectomy Surgery

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

October 15, 2021

Primary Completion Date

March 30, 2022

Study Completion Date

June 30, 2022

Conditions
InflammationInflammatory ResponseAcute PainChronic Pain
Interventions
DRUG

Multimodal analgesia

"Multimodal analgesia includes the combination of:~1. morphine given by PCA (patient-controlled analgesia) at 1 mg/dose~2. bupivacaine 0.25% and dexmedetomidine 0.5 mcg/mL (total volume of 10 mL) by epidural-catheter bolus given preoperatively~3. bupicavaine 0.125% and dexmedetomidine 0.5 mcg/mL at a 5 mL/hour rate per epidural-catheter given intraoperatively~4. bupivacaine 0.1% and dexmedetomidine 0.5 mcg/mL given by programmed intermittent epidural bolus (PIEB), set to be delivered every one-hour~5. etericoxib 90 mg per oral give two-hours before surgery and then continued until three days post-surgery~6. paracetamol 1 g (intravenously) given on the day of the surgery, continued at 10 mg/kg dose every 8 hours until three days post-surgery"

DRUG

Conventional intravenous analgesia

Standard analgesia includes fentanyl 2 mcg/kg (bolus) and morphine given by PCA (patient-controlled analgesia) at 1 mg/dose

Trial Locations (1)

80114

Sanglah General Hospital, Denpasar

All Listed Sponsors
lead

Udayana University

OTHER

NCT05069311 - Effects of Multimodal Analgesia on Serum MCP-1, BDNF, and MiRNA-124 in Hysterectomy Surgery | Biotech Hunter | Biotech Hunter